Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Clinical Neurology
Link
http://link.springer.com/content/pdf/10.1007/s11940-019-0566-1.pdf
Reference107 articles.
1. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci. 2003;206(2):165–71.
2. Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol. 2012;11(12):1082–92. https://doi.org/10.1016/s1474-4422(12)70230-2 .
3. Baldassari LE, Fox RJ. Therapeutic advances and challenges in the treatment of progressive multiple sclerosis. Drugs. 2018;78:1549–66. https://doi.org/10.1007/s40265-018-0984-5 .
4. Ortiz GG, Pacheco-Moises FP, Bitzer-Quintero OK, Ramirez-Anguiano AC, Flores-Alvarado LJ, Ramirez-Ramirez V, et al. Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol. 2013;2013:708659–14. https://doi.org/10.1155/2013/708659 .
5. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol. 2004;251(3):261–8. https://doi.org/10.1007/s00415-004-0348-9 .
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Icariin ameliorates the cuprizone-induced demyelination associated with antioxidation and anti-inflammation;Inflammopharmacology;2024-01-04
2. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis;Journal of Controlled Release;2023-12
3. Effects of Dietary Modification Based on Complementary and Alternative Iranian Medicine in Patients with Secondary-Progressive Multiple Sclerosis: A Randomized Controlled Clinical Trial;Journal of Integrative and Complementary Medicine;2023-11-01
4. Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial;Complementary Therapies in Clinical Practice;2023-11
5. Understanding the Role of Free Radicals and Antioxidant Enzymes in Human Diseases;Current Pharmaceutical Biotechnology;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3